To compare effectiveness, safety and tolerability of Lulican shampoo versus ketoconazole shampoo, in patients having scalp dermatitis.

Phase 4

• Conditions: Health Condition 1: L210- Seborrhea capitis

• Registration Number: CTRI/2021/09/036865
• Lead Sponsor: Anisha Clinic

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Adult patients (18-65 yrs) diagnosed with scalp seborrheic dermatitis and candidates for shampoo therapy at the discretion by treating physician

2. Willing to use shampoo thrice a week as advised

3. Willing to avoid oil application for study duration

4. Patients willing to refrain from other forms of treatment including other topical, oral medication for seborrheic dermatitis

5. Patients who are willing to appear for regular follow ups and follow the prescribed treatment regularly

6. Patients who are willing to give consent to participate in the study

Exclusion Criteria

1. Pregnant/ Planning to conceive/ Lactating women

2. Immunocompromised patients on corticosteroids, other immunosuppressive or biologic drugs

3. Patients suffering from infectious, auto-immune, or other disorders affecting skin of scalp.

4. Documented and known history of severe systemic disease, necessitating medical treatment, as assessed by the investigator that might interfere with the conduct of the study or the interpretation of results.

5. Patients known to be allergic to the any of the components of the study medications.

6. Use of any topical medication including OTC products for dandruff within 14 days of enrolment.

7. Patients who are receiving drugs which are known to affect scalp or hair.

8. Patients with known malignancy.

9. Refusal to participate in the study.

Study & Design

• Study Type: PMS
• Study Design: Not specified